Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Biotech
  • FDA
  • General
  • IPOs
  • News
  • Penny Stocks
  • Small Cap

The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton’s Partnered Epilepsy Drug, ASCO Conference Gets Underway And More

By Shanthi Rexaline
Today, 10:25 PM
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for the year-to-date period.

ABBV

Read More
6 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

88 Biggest Movers From Yesterday

By Lisa Levin
Today, 10:25 PM
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.

AFRM

Read More
2 minute read
  • Penny Stocks
  • Short Ideas
  • Trading Ideas

Short Volatility Alert: Catalyst Biosciences

By Christopher Sappo
Today, 10:25 PM
On Modnay, shares of Catalyst Biosciences, Inc. (NASDAQ: CBIO) experienced volatile short activity. After the activity, the stock price went up +234.21% to $1.27. The overall sentiment for CBIO has been Bearish.

CBIO

Read More
2 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

25 Stocks Moving in Tuesday’s Pre-Market Session

By Lisa Levin
Today, 10:25 PM
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 136.4% to $1.43 in pre-market trading. BOQI International recently posted a Q1 loss of $0.27 per share.

ACRX

Read More
4 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

58 Biggest Movers From Yesterday

By Lisa Levin
Today, 10:25 PM
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.

ADGI

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • M&A
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex

By Vandana Singh
Today, 10:25 PM
Catalyst Biosciences Inc (NASDAQ:CBIO) has agreed to sell its portfolio of protease medicines that regulate complement to Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for $60…

BIIB

Read More
1 minute read
  • Pre-Market Outlook

Benzinga Pro’s Top 5 Stocks To Watch For Monday, May 23, 2022: NVDA, RDBX, CBIO, VRCA, CWH

By Benzinga Newsdesk
Today, 10:25 PM
Today's 5 Stock Ideas: NVIDIA (NVDA) - Will report quarterly results Wednesday after market close. Redbox (RDBX) - One of the most popular stocks among the retail trader group over the last couple weeks.

CBIO

Read More
1 minute read
  • Legal
  • News

Julian Singer Says On April 20, JDS1 Filed Complaint Against Catalyst Biosciences In The Delaware Court Of Chancery

By Benzinga Newsdesk
Today, 10:25 PM
-SEC Filing

CBIO

Read More
2 minute read
  • Earnings

Looking Into Catalyst Biosciences’s Return On Capital Employed

By Benzinga Insights
Today, 10:25 PM
According to data from Benzinga Pro, during Q4, Catalyst Biosciences's (NASDAQ:CBIO) reported sales totaled $2.44 million. Despite a 19.45% increase in earnings, the company posted a loss of $20.33 million.

CBIO

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights
Today, 10:25 PM
Gainers

ARDS

Posts navigation

Previous 1 2 3 … 6 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service